Join to View Full Profile
6560 Fannin StHouston, TX 77030
Phone+1 713-798-4001
Fax+1 713-798-6005
Dr. Lerner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineResidency, Urology, 1986 - 1990
Virginia Mason Franciscan HealthResidency, Surgery, 1984 - 1986- Baylor College of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1990 - Present
TX State Medical License 1985 - 2026
WA State Medical License 1985 - 1987
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Genetic Susceptibility to Bladder Cancer Start of enrollment: 1998 Feb 10
Publications & Presentations
PubMed
- Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive N...Jacob Taylor, Ashish M Kamat, Drupad Annapureddy, Zine-Eddine Khene, Jeffrey Howard
European Urology Oncology. 2025-04-01 - Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning.Zilong Bai, Mohamed Osman, Matthew Brendel, Catherine M Tangen, Thomas W Flaig
NPJ Digital Medicine. 2025-03-22 - Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer.Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, Leslie Ballas, Rick Bangs
Bladder Cancer. 2025-02-24
Press Mentions
Positive Data from Phase 1 Trial of Bel-Sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology CongressMarch 24th, 2025- Bladder Cancer Trial Finds Extended Lymph Node Surgery Doesn’t Improve SurvivalNovember 6th, 2024
- Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder CancerNovember 4th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
